Cullinan Therapeutics, Inc.(CGEM)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Michaelson Jennifer Chief Scientific Officer | Sale | -8,000 | -4.58%166,844 | $14.62 | $116,996 | View SEC filing | |
| 2026-03-09 | Michaelson Jennifer Chief Scientific Officer | Sale | -8,000 | -4.47%170,844 | $15.68 | $125,440 | View SEC filing | |
| 2026-02-26 | Michaelson Jennifer Chief Scientific Officer | Sale | -1,780 | -1.01%174,844 | $14.14 | $25,169 | View SEC filing | |
| 2026-02-25 | Michaelson Jennifer Chief Scientific Officer | Sale | -5,353 | -2.94%176,624 | $14.31 | $76,617 | View SEC filing | |
| 2026-02-25 | AHMED NADIM President and CEO | Sale | -13,515 | -3.34%390,803 | $14.47 | $195,562 | View SEC filing | |
| 2026-02-25 | Jones Jeffrey Alan Chief Medical Officer | Sale | -4,582 | -2.78%159,968 | $14.47 | $66,302 | View SEC filing | |
| 2026-02-25 | SUMER JACQUELYN L Chief Legal Officer | Sale | -3,601 | -2.73%128,089 | $14.47 | $52,106 | View SEC filing | |
| 2026-02-23 | Fenton Mary Kay Chief Financial Officer | Sale | -4,398 | -3.36%126,380 | $13.62 | $59,901 | View SEC filing | |
| 2026-02-23 | Jones Jeffrey Alan Chief Medical Officer | Sale | -4,982 | -2.94%164,550 | $13.62 | $67,855 | View SEC filing | |
| 2026-02-23 | Michaelson Jennifer Chief Scientific Officer | Sale | -11,742 | -2.01%181,977 | $14.08 | $165,366 | View SEC filing | |
| 2026-02-23 | SUMER JACQUELYN L Chief Legal Officer | Sale | -3,742 | -2.76%131,690 | $13.62 | $50,966 | View SEC filing | |
| 2026-02-23 | AHMED NADIM President and CEO | Sale | -16,381 | -3.89%404,318 | $13.62 | $223,109 | View SEC filing | |
| 2026-02-13 | Michaelson Jennifer Chief Scientific Officer | Sale | -416 | -0.32%128,219 | $12.03 | $5,004 | View SEC filing | |
| 2026-01-23 | Michaelson Jennifer Chief Scientific Officer | Sale | -4,000 | -3.02%128,635 | $12.30 | $49,200 | View SEC filing | |
| 2025-12-29 | AHMED NADIM President and CEO | Sale | -9,922 | -2.30%420,699 | $10.01 | $99,319 | View SEC filing | |
| 2025-12-22 | Michaelson Jennifer Chief Scientific Officer | Sale | -1,345 | -1.00%132,635 | $10.01 | $13,463 | View SEC filing | |
| 2025-12-19 | SUMER JACQUELYN L Chief Legal Officer | Sale | -3,480 | -2.51%135,432 | $9.67 | $33,652 | View SEC filing | |
| 2025-12-19 | Jones Jeffrey Alan Chief Medical Officer | Sale | -4,632 | -2.66%169,532 | $9.67 | $44,791 | View SEC filing | |
| 2025-12-19 | Michaelson Jennifer Chief Scientific Officer | Sale | -2,898 | -2.12%133,980 | $9.67 | $28,024 | View SEC filing | |
| 2025-12-16 | Michaelson Jennifer Chief Scientific Officer | Sale | -3,143 | -2.24%136,878 | $12.23 | $38,433 | View SEC filing | |
| 2025-11-25 | Michaelson Jennifer Chief Scientific Officer | Sale | -4,000 | -2.82%138,004 | $12.30 | $49,200 | View SEC filing | |
| 2025-10-30 | Nichols Weston 10% Owner | Purchase | +165,667 | +1.88%8,963,500 | $8.40 | $1,391,686 | View SEC filing | |
| 2025-10-21 | Nichols Weston 10% Owner | Purchase | +248,749 | +1.45%17,361,949 | $8.46 | $2,103,912 | View SEC filing | |
| 2025-10-10 | Nichols Weston 10% Owner | Purchase | +1,459,641 | +9.91%16,194,827 | $6.73 | $9,826,941 | View SEC filing | |
| 2025-02-27 | Jones Jeffrey Alan Chief Medical Officer | Sale | -4,895 | -2.73%174,164 | $8.53 | $41,754 | View SEC filing |
1-25 of 129